Table 1:
PXA (n = 10) | APXA (n = 9) | P Value | |
---|---|---|---|
Clinical data | |||
Male sex (No.) (%) | 6 (46.2%) | 4 (44.4%) | .604 |
Mean age (yr) | 32.8 ± 22.3 | 47.7 ± 11.7 | .09 |
Location (No.) | .905 | ||
Frontal lobe | 2 | 2 | |
Temporal lobe | 5 | 3 | |
Occipital lobe | 1 | ||
Parietal lobe | 2 | 3 | |
Superficial location (No.) (%) | 9 (90%) | 8 (88.9%) | .720 |
Conventional MR imaging | |||
Mean size (cm) | 3.1 ± 1.1 | 4.7 ± 0.6 | .001 |
Presence of cystic degeneration (No.) (%) | 7 (70.0%) | 8 (88.9%) | .497 |
Peritumoral edema (mean) (cm) | 1.0 ± 0.9 | 2.3 ± 0.9 | .008 |
Heterogeneous enhancement (No.) (%) | 2 (20.0%) | 8 (88.9%) | .01 |
Leptomeningeal contact (No.) (%) | 9 (90%) | 7 (77.8%) | .661 |